Clinical trials in Hodgkin lymphoma


The table below shows a list of The Lymphoma Group's current clinical trials open for recruitment for Hodgkin lymphoma patients.

 If you would like to know how to access our trials please click here


Trial Name




Click for more information (external page)




A phase II study testing a targeted drug called nivolumab

Suitable for patients with lymphoma which has come back after previous treatment






A phase II trial of avelumab for untreated advanced classical Hodgkin lymphoma.

Suitable for patients with classical Hodgkin lymphoma who have not yet received treatment




With special thanks to the following:

Last updated: October 2021